IPGP

IPG Photonics Corporation
NASDAQTECHNOLOGYSEMICONDUCTOR EQUIPMENT & MATERIALS

Key Statistics

Market Cap
$3.02B
P/E Ratio
109.25
EPS
$0.65
Beta
0.97
52W High
$155.82
52W Low
$69.41
50-Day MA
$78.86
200-Day MA
$101.42
Dividend Yield
—
Profit Margin
2.58%
Forward P/E
32.36
PEG Ratio
1.83

About IPG Photonics Corporation

IPG Photonics is a manufacturer of fiber lasers.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$1.07B
Gross Profit (TTM)$405.05M
EBITDA$104.39M
Operating Margin5.90%
Return on Equity1.30%
Return on Assets0.97%
Revenue/Share (TTM)$25.31
Book Value$50.01
Price-to-Book1.54
Price-to-Sales (TTM)2.83
EV/Revenue2.27
EV/EBITDA22.18
Quarterly Earnings Growth (YoY)-22.80%
Quarterly Revenue Growth (YoY)11.10%
Shares Outstanding$42.53M
Float$27.84M
% Insiders38.98%
% Institutions75.49%

Historical Volatility

HV 10-Day
29.46%
HV 20-Day
38.29%
HV 30-Day
39.70%
HV 60-Day
52.26%
HV Rank
19.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($124.14 target)
2
Strong Buy
4
Buy
2
Hold
1
Strong Sell

Latest News

IPG Defense to Display CROSSBOW™ High-Energy Laser Systems at Land Forces 2026 in Perth

MARLBOROUGH, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- IPG Photonics today announced that from October 6th though October 8th, 2026, IPG Defense will participate in Land Forces 2026 in Perth, Australia to showcase CROSSBOW™ High-Energy Laser (HEL) Systems. This key industry event provides a platform to forge strategic alliances and collaborate to shape the future of the global aerospace and defense market.

GlobeNewsWire10/5/2026Neutral
NTHM's Index Rebalance Puts Thematic Rotation to Work

The latest rebalance of VettaFi's Thematic Rotation Quality Momentum Screened Index (TQRMS), tracked by the NBI Thematic Rotation ETF (NTHM:TSX), reshapes the portfolio around a new set of themes. GLP-1 weight loss drug manufacturers and midstream energy join the index, while battery technology & storage and software-as-a-service (SaaS) exit.

ETF Trends9/25/2026Neutral
IPG Photonics: Bullish On Business Mix Enhancement

I initiate coverage on IPG Photonics with a 'Buy' rating, citing a compelling business mix transition. IPGP's acquisition of Lumibird Medical boosts exposure to the medical end -market, boasting a superior financial profile than its legacy operations. The company is shifting organically toward promising business areas like AI, defense, and medical.

Seeking Alpha9/21/2026Positive
IPG (IPGP) Upgraded to Buy: Here's Why

IPG (IPGP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research8/6/2026Positive
IPG Photonics Q2 Earnings Call Highlights

IPG Photonics NASDAQ: IPGP reported second-quarter 2026 revenue of $279 million, up 11% from a year earlier and representing its third consecutive quarter of double-digit year-over-year sales growth. Revenue exceeded the midpoint of the company's guidance, while bookings improved and book-to-bill remained above one, according to management.

MarketBeat8/4/2026Positive
IPG Photonics (IPGP) Surpasses Q2 Earnings Estimates

IPG Photonics (IPGP) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.3 per share a year ago.

Zacks Investment Research8/4/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on IPGP and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More TECHNOLOGY Stocks

Data last updated: 10/17/2026